USP30 inhibitors (Progenra)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameUSP30 inhibitors (Progenra)

Drug Alias Nameubiquitin specific peptidase 30 (Progenra)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionUbiquitin carboxyl-terminal hydrolase 30 inhibitorsSerine/threonine-protein kinase PINK1, mitochondrial degradersE3 ubiquitin-protein ligase parkin inhibitors

TargetsSerine/threonine-protein kinase PINK1, mitochondrialUbiquitin carboxyl-terminal hydrolase 30E3 ubiquitin-protein ligase parkin

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesProgenra Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesProgenra Inc

Active IndicationsN/A

Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A